Matinas BioPharma Holdings (MTNB) Intangibles (2015 - 2026)

Matinas BioPharma Holdings (MTNB) has 12 years of Intangibles data on file, last reported at $2.3 million in Q1 2026.

• Intangibles for Q1 2026 came in at $2.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (changed 0.0% YoY), and the FY2025 annual result was $2.3 million, changed 0.0% from the prior year.
• Intangibles held at $2.3 million in Q1 2026 per MTNB's latest filing, from $2.3 million in the prior quarter.
• Over five years, Intangibles peaked at $3.0 million in Q1 2022 and troughed at $2.3 million in Q4 2024.
• A 5-year average of $2.7 million and a median of $3.0 million in 2022 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2024: Intangibles changed 0.0% in 2022, then fell 25.09% in 2024.
• A 5-year view of Intangibles shows it stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then dropped by 25.09% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
• Business Quant data shows MTNB's Intangibles at $2.3 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.